Last checked at 23 May 2018 12:29
23 May 2018
Venture Life Group plc
("Venture Life" or "the Company")
Result of AGM
Venture Life (AIM: VLG), the international consumer self-care company focused on developing, manufacturing and commercialising products for the self-care market, announces that at its Annual General Meeting held earlier today, all resolutions were duly passed.
Enquiries
Venture Life Group PLC | +44 (0) 1344 742870 | |
Jerry Randall, Chief Executive Officer | ||
Adrian Crockett, Chief Financial Officer | ||
Northland Capital Partners Limited (Nominated Adviser and Joint Broker) | +44 (0) 20 3861 6625 | |
Matthew Johnson / Edward Hutton (Corporate Finance) | ||
John Howes / Vadim Alexandre (Corporate Broking) | ||
Turner Pope Investments (TPI) Ltd (Joint Broker) | +44 (0) 20 3621 4120 | |
James Pope / Ben Turner | ||
Walbrook PR | venturelife@walbrookpr.com or + 44 (0) 20 7933 8780 | |
Anna Dunphy /Paul McManus | +44 (0) 7876 741 001 / +44 (0) 7980 541 893 | |
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its Development and Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.